Ventas Reports 13 Percent Increase in 2012 Normalized FFO to $3.80 Per Diluted Share
Company Generates Record Cash Flows Guidance for 2013 Normalized FFO Per Diluted Share Ranges Between
$3.99 and $4.07
Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) said today that
normalized Funds From Operations (“FFO”) for the year ended December 31,
2012 increased 44 percent to $1.1 billion, from $777.0 million for the
comparable 2011 period. Normalized FFO per diluted common share was
$3.80 for the year ended December 31, 2012, a 13 percent increase from
$3.37 for the comparable 2011 period. Weighted average diluted shares
outstanding for the full year rose by 28 percent to 294.5 million,
compared to 230.8 million in 2011.
The substantial growth in 2012 normalized FFO per diluted common share
compared to 2011 is due primarily to the Company's $2.7 billion of
investments in 2012 and the full-year benefit of the Company's 2011
acquisitions, including Nationwide Health Properties, Inc. (“NHP”) and
the portfolio of senior living communities managed by Atria Senior
Living, Inc. (“Atria”). Additionally, the Company benefited from
excellent performance by its seniors housing communities managed by
Atria and Sunrise Senior Living, LLC (“Sunrise”), rental increases from
its triple-net lease portfolio and lower weighted average interest
rates. These benefits were partially offset by higher debt balances, an
increase in the Sunrise management fee, increases in general and
administrative expenses, asset sales and loan repayments in 2011 and
2012 and an increase in weighted average diluted shares outstanding.
“Ventas had another outstanding year of internal and external growth,
execution of our long-term strategy and performance, delivering over 22
percent total returns to shareholders and producing record cash flows,”
Ventas Chairman and Chief Executive Officer Debra A. Cafaro said.
“Working collaboratively, our team harnessed the power of our scale and
platform to make $2.7 billion in accretive private pay investments,
raise capital efficiently and manage our assets to drive strong growth
in 2012. For more than a dozen years, Ventas has fulfilled its
commitments with consistent superior performance and a strong financial
profile, sustaining excellence throughout our Company,” she added.
Normalized FFO for the year ended December 31, 2012 excludes the net
expense (totaling $95.7 million, or $0.32 per diluted share) from
merger-related expenses and deal costs (including integration costs),
loss on extinguishment of debt and amortization of other intangibles,
partially offset by income tax benefit. Normalized FFO for the year
ended December 31, 2011 excluded the net benefit (totaling $47.9
million, or $0.21 per diluted share) from net litigation proceeds and
income tax benefit, partially offset by merger-related expenses and deal
costs (including integration costs), loss on extinguishment of debt,
amortization of other intangibles and mark-to-market adjustment for
derivatives.
Net income attributable to common stockholders for the year ended
December 31, 2012 was $362.8 million, or $1.23 per diluted common share,
including discontinued operations of $57.2 million. Net income
attributable to common stockholders for the year ended December 31, 2011
was $364.5 million, or $1.58 per diluted common share, including
discontinued operations of $1.4 million. This $1.7 million decrease in
net income attributable to common stockholders in 2012 over the prior
year is primarily the result of the receipt of net litigation proceeds
totaling $202.3 million from HCP, Inc. (the “Litigation Proceeds”) in
2011 and higher depreciation in 2012, almost entirely offset by the
growth experienced by the Company in 2012 and 2011, as described above.
Excluding the Litigation Proceeds from 2011 results, 2012 net income
attributable to common stockholders rose by 124 percent, or 76 percent
per diluted share. The Company recognized a net gain of $97.6 million
during 2012 from real estate activity, which gain is excluded from both
normalized FFO and NAREIT FFO (as defined below).
FFO, as defined by the National Association of Real Estate Investment
Trusts (“NAREIT”), for the year ended December 31, 2012 increased 24
percent to $1.0 billion, from $824.9 million in the comparable 2011
period. This increase is due primarily to the factors described above
for net income excluding the net impact of gains from real estate
activity and depreciation.
NAREIT FFO per diluted common share for the year ended December 31, 2012
decreased 2.5 percent to $3.48, from $3.57 in 2011, due principally to
the receipt of the Litigation Proceeds in 2011 and higher weighted
average diluted shares outstanding in 2012. Excluding the Litigation
Proceeds from 2011 results, 2012 FFO rose by 65 percent, or 29 percent
per diluted share.
FOURTH QUARTER 2012
Fourth quarter 2012 normalized FFO increased 13 percent to $293.6
million, from $259.3 million for the comparable 2011 period. Normalized
FFO per diluted common share was $0.99 for the quarter ended December
31, 2012, an increase of 11 percent from $0.89 for the comparable 2011
period. Weighted average diluted shares outstanding for the fourth
quarter rose by two percent to 297.1 million, compared to 290.6 million
in 2011.
Net income attributable to common stockholders for the quarter ended
December 31, 2012 was $86.3 million, or $0.29 per diluted common share,
including expense associated with discontinued operations of $11.7
million, compared with net income attributable to common stockholders
for the quarter ended December 31, 2011 of $192.9 million, or $0.66 per
diluted common share, including expense associated with discontinued
operations of $0.6 million and the Litigation Proceeds of $116.9 million
received in the fourth quarter of 2011.
NAREIT FFO for the quarter ended December 31, 2012 was $284.0 million, a
decrease from $359.1 million in the comparable 2011 period. NAREIT FFO
per diluted common share for the quarter ended December 31, 2012
decreased 23 percent to $0.96, from $1.24 in 2011. This decrease is
primarily due to the receipt of $116.9 million in Litigation Proceeds in
the fourth quarter of 2011 and higher weighted average diluted shares
outstanding in 2012.
FIRST QUARTER DIVIDEND INCREASES EIGHT PERCENT TO $0.67 PER COMMON
SHARE
Ventas also said today that its Board of Directors increased the
Company's first quarter 2013 dividend by eight percent to $0.67 per
share. The dividend is payable in cash on March 28, 2013 to stockholders
of record on March 8, 2013.
“Sustained dividend growth is an important part of the consistent
superior total returns we aim to provide our investors. We are pleased
to increase our first quarter dividend by eight percent, which reflects
our strong cash flow growth and our confidence in our business and our
opportunities,” Cafaro said.
PRIVATE PAY SENIORS HOUSING OPERATING PORTFOLIO
Annual Total Portfolio NOI Exceeds $386 Million, Quarterly
Same-Store NOI Grows 6.2 Percent and Occupancy Rises 360 Basis Points
At December 31, 2012, the Company's seniors housing operating portfolio
included 125 private pay seniors housing communities managed by Atria
and 95 private pay seniors housing communities managed by Sunrise. Net
Operating Income (“NOI”) for this portfolio totaled $386.6 million after
management fees and $455.8 million before management fees, including
discontinued operations and recent acquisitions. Excluding results from
seniors housing communities acquired in December and, therefore, not in
the Company's previous NOI guidance of $383 million to $385 million, NOI
for 2012 totaled $386.2 million.
One hundred ninety-four of these private pay seniors housing communities
were owned by the Company for the full fourth quarters of 2012 and 2011
(“same-store”). Average unit occupancy in the same-store communities
rose 360 basis points to 91.9 percent in the fourth quarter of 2012
compared to the fourth quarter of 2011.
NOI before management fees for these same-store communities increased
6.2 percent to $107.3 million in the fourth quarter of 2012, versus
$101.0 million in the fourth quarter of 2011. Same-store NOI after
management fees increased by 2.1 percent, from $88.8 million in the
fourth quarter of 2011 to $90.6 million in the fourth quarter of 2012.
The Sunrise management fee increased in 2012 to its contractual level.
2012 RECAP
Investments and Dispositions
-
Ventas closed $2.7 billion in investments during 2012, including
Cogdell Spencer, Inc. and 16 private pay seniors housing communities
managed by Sunrise. Excluding the Atria transaction described below,
the current unlevered cash yield on these investments approximates
eight percent. Private pay assets accounted for 97 percent of the
investments. Fourth quarter investments totaling $1 billion included
seniors housing assets, medical office buildings and secured loans.
-
Ventas acquired 100 percent of various private investment funds (the
“Funds”) previously managed by Lazard Frères Real Estate Investors LLC
or its affiliates. The acquired Funds now own, among other things, (a)
a 34 percent interest in Atria and (b) 3.7 million shares of Ventas
common stock. The total purchase price for these interests was
approximately $242 million. The Atria management team now owns the
remaining 66 percent of Atria. Ventas also extinguished its obligation
related to the “Earnout,” a contingent performance-based payment, for
an additional $44 million, which represented the discounted net
present value of the Earnout on the Company's balance sheet.
-
During 2012, Ventas sold 43 properties and received final repayment on
loans totaling $422 million in aggregate proceeds, including certain
fees. The Company recognized a net gain of $81.0 million from these
dispositions. In the fourth quarter, Ventas sold assets and received
final repayment on loans totaling $120 million in aggregate proceeds
and recognized a net gain.
Returns and Dividends
-
Ventas delivered total shareholder return (“TSR”) of 22.3 percent in
2012 and 25.1 percent compound annual TSR for the ten-year period
ended December 31, 2012. Ventas TSR exceeded the RMS and S&P 500 Index
in each of the trailing one-, three-, five- and ten-year periods.
-
Ventas paid an annual per share dividend of $2.48 in 2012, an eight
percent increase over the prior year.
Liquidity, Capital Raising, Ratings and
Balance Sheet
-
Ventas maintains investment grade ratings from all three nationally
recognized rating agencies, and Moody's improved its outlook to
“positive” in December 2012. Ventas's senior unsecured debt is
currently rated BBB+ (stable) by Fitch, Baa2 (positive) by Moody's and
BBB (stable) by Standard & Poor's.
-
Ventas issued and sold $2.6 billion aggregate principal amount of
senior notes and term loan at a weighted average stated interest rate
of 3.2 percent and a weighted average maturity at the time of issuance
of 7.7 years and redeemed or repaid $780.4 million aggregate principal
amount of its outstanding unsecured debt and $344.2 million of
mortgage debt. The $2.6 billion includes the previously announced $700
million aggregate principal amount of 2.00 percent senior notes due
2018 and the $225 million aggregate principal amount of 3.25 percent
senior notes due 2022 the Company issued in December 2012.
-
Ventas sold approximately 6 million shares of its common stock in an
underwritten public offering and received proceeds of $342.5 million
and ended the year with 291.9 million shares outstanding.
-
The Company's debt to total capitalization at December 31, 2012 was
approximately 31 percent.
-
The Company's net debt to Adjusted Pro Forma EBITDA (as defined
herein) at December 31, 2012 was 5.4x.
-
At December 31, 2012, the Company had $541 million of borrowings
outstanding under its unsecured revolving credit facility and $68
million of cash and cash equivalents.
Cash Flow Growth
-
Cash flows from operations totaled $992.8 million in 2012, an increase
of 74 percent over the prior year, excluding the $202.3 million of
Litigation Proceeds received in 2011. The Company generated
approximately $195 million in cash flows from operations in 2012 after
recurring capital expenditures and dividends. Weighted average diluted
shares outstanding rose 28 percent year over year.
-
“Same-store” cash NOI growth for the Company's total portfolio (525
assets) was 4.4 percent in 2012 compared to 2011, excluding the
Sunrise management fee in both periods.
PORTFOLIO, UPDATE ON RE-LEASING & ADDITIONAL INFORMATION
-
Ventas has now entered into lease renewals, new leases or sale
contracts for all 89 licensed healthcare facilities currently leased
by Kindred Healthcare, Inc. (NYSE: KND) (“Kindred”) whose lease term
was up for renewal May 1, 2013. The Company expects 2013 cash revenue
and NOI from these 89 assets to be $125 million, compared to 2012 rent
for all 89 facilities of $125 million, consistent with Ventas's
expectations. Of the 54 properties marketed by Ventas, 49 properties
have been leased to seven qualified skilled nursing facility
operators, and five assets are under contract for sale. Kindred has
renewed or entered into a new lease for 35 properties. While
definitive agreements have been executed for all 54 marketed
properties and Ventas expects all transactions to be completed, and
for operating transitions to occur, during the first half of 2013,
these transactions and operating transitions remain subject to normal
closing conditions, including regulatory approval. Accordingly, there
can be no assurance that the transactions will be completed, that the
expected operating transitions will occur or that projected revenue
and/or NOI will be achieved by the Company. More information on these
2013 renewal assets is contained at www.ventasreit.com/investor-relations.
-
The 196 skilled nursing facilities (“SNFs”) and long-term acute care
hospitals (“LTACs”) master leased by the Company to Kindred produced
EBITDARM (earnings before interest, taxes, depreciation, amortization,
rent and management fees) to actual cash rent coverage of 1.9x for the
trailing 12-month period ended September 30, 2012 (the latest date
available).
-
Supplemental information regarding the Company can be found on the
Company's website under the “Investor Relations” section or at www.ventasreit.com/investor-relations/financial-information/supplemental-information.
VENTAS ISSUES 2013 NORMALIZED FFO PER DILUTED SHARE GUIDANCE OF $3.99
TO $4.07
Ventas currently expects its 2013 normalized FFO per diluted share,
excluding the impact of unannounced acquisitions, divestitures and
capital transactions, to range between $3.99 and $4.07. The Company now
expects 2013 NOI for its total Atria- and Sunrise-managed seniors
housing operating portfolio to be between $430 million and $440 million,
representing approximately five to eight percent same-store NOI growth.
The Company's guidance assumes first quarter investments approximating
$100 million and dispositions and loan repayments approximating $300
million during the year. In addition, the guidance assumes $400 million
of debt issuance.
Excluding non-cash items from normalized FFO (projected to be $0.12 per
diluted share), computed consistent with prior periods, the midpoint of
the Company's guidance range constitutes approximately nine percent per
share growth in 2013. A reconciliation of the Company's guidance, and
the non-cash items, to the Company's projected GAAP earnings is attached
to this press release at page 12.
The Company's normalized FFO guidance (and related GAAP earnings
projections) for all periods assumes, with certain immaterial
exceptions, that all of the Company's tenants and borrowers continue to
meet all of their obligations to the Company. In addition, the Company's
normalized FFO guidance excludes, other than as specifically stated, (a)
net gains on the sales of real property assets, including gain on
re-measurement of equity method investments, (b) merger-related costs
and expenses, including amortization of intangibles and transition and
integration expenses, and deal costs and expenses, (c) the impact of any
expenses related to asset impairment and valuation allowances, the
write-off of unamortized deferred financing fees, or additional costs,
expenses, discounts, make-whole payments, penalties or premiums incurred
as a result of early retirement or payment of the Company's debt, (d)
the non-cash effect of income tax benefits or expenses and derivative
transactions that have non-cash mark-to-market impacts on the Company's
income statement, and (e) the impact of future unannounced acquisitions
or divestitures (including pursuant to tenant options to purchase) and
capital transactions.
The Company's guidance is based on a number of other assumptions that
are subject to change and many of which are outside the control of the
Company. If actual results vary from these assumptions, the Company's
expectations may change. There can be no assurance that the Company will
achieve these results. The Company may from time to time update its
publicly announced guidance, but it is not obligated to do so.
FOURTH QUARTER CONFERENCE CALL
Ventas will hold a conference call to discuss this earnings release
today at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in
number for the conference call is (617) 597-5380. The participant
passcode is “Ventas.” The conference call is being webcast live by
Thomson Reuters and can be accessed at the Company's website at www.ventasreit.com
or www.earnings.com.
A replay of the webcast will be available today online, or by calling
(617) 801-6888, passcode 18439203, beginning at approximately 12:00 p.m.
Eastern Time and will be archived for 28 days.
Ventas, Inc., an S&P 500 company, is a leading healthcare real estate
investment trust. Its diverse portfolio of more than 1,400 assets in 47
states (including the District of Columbia) and two Canadian provinces
consists of seniors housing communities, skilled nursing facilities,
hospitals, medical office buildings and other properties. Through its
Lillibridge subsidiary, Ventas provides management, leasing, marketing,
facility development and advisory services to highly rated hospitals and
health systems throughout the United States. More information about
Ventas and Lillibridge can be found at www.ventasreit.com
and www.lillibridge.com.
This press release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. All
statements regarding the Company's or its tenants', operators',
managers' or borrowers' expected future financial condition, results of
operations, cash flows, funds from operations, dividends and dividend
plans, financing opportunities and plans, capital markets transactions,
business strategy, budgets, projected costs, operating metrics, capital
expenditures, competitive positions, acquisitions, investment
opportunities, dispositions, merger integration, growth opportunities,
expected lease income, continued qualification as a real estate
investment trust (“REIT”), plans and objectives of management for future
operations and statements that include words such as “anticipate,” “if,”
“believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,”
“should,” “will” and other similar expressions are forward-looking
statements. These forward-looking statements are inherently
uncertain, and actual results may differ from the Company's expectations.
The Company does not undertake a duty to update these forward-looking
statements, which speak only as of the date on which they are made.
The Company's actual future results and trends may differ materially
from expectations depending on a variety of factors discussed in the
Company's filings with the Securities and Exchange Commission. These
factors include without limitation: (a) the ability and willingness of
the Company's tenants, operators, borrowers, managers and other third
parties to satisfy their obligations under their respective contractual
arrangements with the Company, including, in some cases, their
obligations to indemnify, defend and hold harmless the Company from and
against various claims, litigation and liabilities; (b) the ability of
the Company's tenants, operators, borrowers and managers to maintain the
financial strength and liquidity necessary to satisfy their respective
obligations and liabilities to third parties, including without
limitation obligations under their existing credit facilities and other
indebtedness; (c) the Company's success in implementing its business
strategy and the Company's ability to identify, underwrite, finance,
consummate and integrate diversifying acquisitions and investments,
including investments in different asset types and outside the United
States; (d) macroeconomic conditions such as a disruption of or lack of
access to the capital markets, changes in the debt rating on U.S.
government securities, default or delay in payment by the United States
of its obligations, and changes in the federal budget resulting in the
reduction or nonpayment of Medicare or Medicaid reimbursement rates; (e)
the nature and extent of future competition; (f) the extent of future or
pending healthcare reform and regulation, including cost containment
measures and changes in reimbursement policies, procedures and rates;
(g) increases in the Company's borrowing costs as a result of changes in
interest rates and other factors; (h) the ability of the Company's
operators and managers, as applicable, to comply with laws, rules and
regulations in the operation of the Company's properties, to deliver
high quality services, to attract and retain qualified personnel and to
attract residents and patients; (i) changes in general economic
conditions or economic conditions in the markets in which the Company
may, from time to time, compete, and the effect of those changes on the
Company's revenues, earnings and funding sources; (j) the Company's
ability to pay down, refinance, restructure or extend its indebtedness
as it becomes due; (k) the Company's ability and willingness to maintain
its qualification as a REIT due to economic, market, legal, tax or other
considerations; (l) final determination of the Company's taxable net
income for the year ended December 31, 2012 and the year ending December
31, 2013; (m) the ability and willingness of the Company's tenants to
renew their leases with the Company upon expiration of the leases, the
Company's ability to reposition its properties on the same or better
terms in the event of nonrenewal or in the event the Company exercises
its right to replace an existing tenant, and obligations, including
indemnification obligations, the Company may incur in connection with
the replacement of an existing tenant; (n) risks associated with the
Company's senior living operating portfolio, such as factors that can
cause volatility in the Company's operating income and earnings
generated by those properties, including without limitation national and
regional economic conditions, costs of food, materials, energy, labor
and services, employee benefit costs, insurance costs and professional
and general liability claims, and the timely delivery of accurate
property-level financial results for those properties; (o) changes in
U.S. and Canadian currency exchange rates; (p) year-over-year changes in
the Consumer Price Index and the effect of those changes on the rent
escalators contained in the Company's leases, including the rent
escalators for two of the Company's master lease agreements with
Kindred, and the Company's earnings; (q) the Company's ability and the
ability of its tenants, operators, borrowers and managers to obtain and
maintain adequate property, liability and other insurance from
reputable, financially stable providers; (r) the impact of increased
operating costs and uninsured professional liability claims on the
liquidity, financial condition and results of operations of the
Company's tenants, operators, borrowers and managers, and the ability of
the Company's tenants, operators, borrowers and managers to accurately
estimate the magnitude of those claims; (s) risks associated with the
Company's MOB portfolio and operations, including the Company's ability
to successfully design, develop and manage MOBs, to accurately estimate
its costs in fixed fee-for-service projects and to retain key personnel;
(t) the ability of the hospitals on or near whose campuses the Company's
MOBs are located and their affiliated health systems to remain
competitive and financially viable and to attract physicians and
physician groups; (u) the Company's ability to build, maintain and
expand its relationships with existing and prospective hospital and
health system clients; (v) risks associated with the Company's
investments in joint ventures and unconsolidated entities, including its
lack of sole decision-making authority and its reliance on its joint
venture partners' financial condition; (w) the impact of market or
issuer events on the liquidity or value of the Company's investments in
marketable securities; (x) merger and acquisition activity in the
healthcare industry resulting in a change of control of one or more of
our tenants, operators, borrowers or managers or significant changes in
the senior management of our tenants, operators, borrowers or managers;
and (y) the impact of litigation or any financial, accounting, legal or
regulatory issues that may affect the Company or its tenants, operators,
borrowers or managers. Many of these factors are beyond the
control of the Company and its management.
|
CONSOLIDATED BALANCE SHEETS
|
As of December 31, 2012, September 30, 2012, June 30, 2012, March
31, 2012 and December 31, 2011
|
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31,
|
|
September 30,
|
|
June 30,
|
|
March 31,
|
|
December 31,
|
|
|
2012
|
|
2012
|
|
2012
|
|
2012
|
|
2011
|
Assets
|
|
|
|
|
|
|
|
|
|
|
Real estate investments:
|
|
|
|
|
|
|
|
|
|
|
Land and improvements
|
|
$
|
1,772,417
|
|
|
$
|
1,754,826
|
|
|
$
|
1,744,752
|
|
|
$
|
1,616,947
|
|
|
$
|
1,614,847
|
|
Buildings and improvements
|
|
16,920,821
|
|
|
16,552,534
|
|
|
16,181,392
|
|
|
15,329,730
|
|
|
15,337,919
|
|
Construction in progress
|
|
70,665
|
|
|
93,992
|
|
|
133,890
|
|
|
85,418
|
|
|
76,638
|
|
Acquired lease intangibles
|
|
981,704
|
|
|
965,500
|
|
|
920,116
|
|
|
799,136
|
|
|
800,858
|
|
|
|
19,745,607
|
|
|
19,366,852
|
|
|
18,980,150
|
|
|
17,831,231
|
|
|
17,830,262
|
|
Accumulated depreciation and amortization
|
|
(2,634,075
|
)
|
|
(2,447,175
|
)
|
|
(2,256,197
|
)
|
|
(2,084,212
|
)
|
|
(1,916,530
|
)
|
Net real estate property
|
|
17,111,532
|
|
|
16,919,677
|
|
|
16,723,953
|
|
|
15,747,019
|
|
|
15,913,732
|
|
Secured loans receivable, net
|
|
635,002
|
|
|
215,775
|
|
|
213,193
|
|
|
222,218
|
|
|
212,577
|
|
Investments in unconsolidated entities
|
|
95,409
|
|
|
90,992
|
|
|
104,636
|
|
|
106,086
|
|
|
105,303
|
|
Net real estate investments
|
|
17,841,943
|
|
|
17,226,444
|
|
|
17,041,782
|
|
|
16,075,323
|
|
|
16,231,612
|
|
Cash and cash equivalents
|
|
67,908
|
|
|
58,530
|
|
|
52,803
|
|
|
53,224
|
|
|
45,807
|
|
Escrow deposits and restricted cash
|
|
105,913
|
|
|
76,908
|
|
|
114,883
|
|
|
114,420
|
|
|
76,590
|
|
Deferred financing costs, net
|
|
42,551
|
|
|
25,426
|
|
|
25,750
|
|
|
26,601
|
|
|
26,669
|
|
Other assets
|
|
921,685
|
|
|
1,053,591
|
|
|
987,043
|
|
|
919,391
|
|
|
891,232
|
|
Total assets
|
|
$
|
18,980,000
|
|
|
$
|
18,440,899
|
|
|
$
|
18,222,261
|
|
|
$
|
17,188,959
|
|
|
$
|
17,271,910
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and equity
|
|
|
|
|
|
|
|
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
Senior notes payable and other debt
|
|
$
|
8,413,646
|
|
|
$
|
7,494,774
|
|
|
$
|
7,204,727
|
|
|
$
|
6,430,364
|
|
|
$
|
6,429,116
|
|
Accrued interest
|
|
47,565
|
|
|
56,326
|
|
|
47,842
|
|
|
58,041
|
|
|
37,694
|
|
Accounts payable and other liabilities
|
|
995,156
|
|
|
1,049,043
|
|
|
1,059,385
|
|
|
1,060,647
|
|
|
1,085,597
|
|
Deferred income taxes
|
|
259,715
|
|
|
265,116
|
|
|
271,066
|
|
|
271,408
|
|
|
260,722
|
|
Total liabilities
|
|
9,716,082
|
|
|
8,865,259
|
|
|
8,583,020
|
|
|
7,820,460
|
|
|
7,813,129
|
|
|
|
|
|
|
|
|
|
|
|
|
Redeemable OP unitholder and noncontrolling interests
|
|
174,555
|
|
|
113,908
|
|
|
116,635
|
|
|
106,264
|
|
|
102,837
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity:
|
|
|
|
|
|
|
|
|
|
|
Ventas stockholders' equity:
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, $1.00 par value; 10,000 shares authorized,
unissued
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
Common stock, $0.25 par value; 295,565, 295,534, 295,370, 289,027,
and 288,823 shares issued at December 31, 2012, September 30,
2012, June 30, 2012, March 31, 2012 and December 31, 2011,
respectively
|
|
73,904
|
|
|
73,896
|
|
|
73,855
|
|
|
72,273
|
|
|
72,240
|
|
Capital in excess of par value
|
|
9,920,962
|
|
|
9,941,030
|
|
|
9,932,839
|
|
|
9,591,880
|
|
|
9,593,583
|
|
Accumulated other comprehensive income
|
|
23,354
|
|
|
23,626
|
|
|
21,404
|
|
|
23,926
|
|
|
22,062
|
|
Retained earnings (deficit)
|
|
(777,927
|
)
|
|
(680,888
|
)
|
|
(609,487
|
)
|
|
(500,808
|
)
|
|
(412,181
|
)
|
Treasury stock, 3,699, 0, 0, 10 and 14 shares at December 31,
2012, September 30, 2012, June 30, 2012, March 31, 2012 and
December 31, 2011, respectively
|
|
(221,165
|
)
|
|
—
|
|
|
—
|
|
|
(536
|
)
|
|
(747
|
)
|
Total Ventas stockholders' equity
|
|
9,019,128
|
|
|
9,357,664
|
|
|
9,418,611
|
|
|
9,186,735
|
|
|
9,274,957
|
|
Noncontrolling interest
|
|
70,235
|
|
|
104,068
|
|
|
103,995
|
|
|
75,500
|
|
|
80,987
|
|
Total equity
|
|
9,089,363
|
|
|
9,461,732
|
|
|
9,522,606
|
|
|
9,262,235
|
|
|
9,355,944
|
|
Total liabilities and equity
|
|
$
|
18,980,000
|
|
|
$
|
18,440,899
|
|
|
$
|
18,222,261
|
|
|
$
|
17,188,959
|
|
|
$
|
17,271,910
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF INCOME
|
For the three months and years ended December 31, 2012 and 2011
|
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months
|
|
For the Years
|
|
|
Ended December 31,
|
|
Ended December 31,
|
|
|
|
|
|
|
|
|
|
|
|
2012
|
|
2011
|
|
2012
|
|
2011
|
Revenues:
|
|
|
|
|
|
|
|
|
Rental income:
|
|
|
|
|
|
|
|
|
Triple-net leased
|
|
$
|
209,922
|
|
|
$
|
204,169
|
|
|
$
|
831,221
|
|
|
$
|
637,294
|
|
Medical office buildings
|
|
108,951
|
|
|
60,008
|
|
|
362,839
|
|
|
166,161
|
|
|
|
318,873
|
|
|
264,177
|
|
|
1,194,060
|
|
|
803,455
|
|
Resident fees and services
|
|
322,533
|
|
|
277,992
|
|
|
1,229,479
|
|
|
868,095
|
|
Medical office building and other services revenue
|
|
3,950
|
|
|
10,421
|
|
|
20,741
|
|
|
36,471
|
|
Income from loans and investments
|
|
14,690
|
|
|
9,867
|
|
|
39,913
|
|
|
34,415
|
|
Interest and other income
|
|
665
|
|
|
688
|
|
|
1,106
|
|
|
1,217
|
|
Total revenues
|
|
660,711
|
|
|
563,145
|
|
|
2,485,299
|
|
|
1,743,653
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
Interest
|
|
76,700
|
|
|
67,443
|
|
|
293,401
|
|
|
229,346
|
|
Depreciation and amortization
|
|
187,754
|
|
|
161,439
|
|
|
725,981
|
|
|
447,664
|
|
Property-level operating expenses:
|
|
|
|
|
|
|
|
|
Senior living
|
|
223,115
|
|
|
188,790
|
|
|
843,190
|
|
|
590,151
|
|
Medical office buildings
|
|
39,684
|
|
|
20,018
|
|
|
126,152
|
|
|
57,042
|
|
|
|
262,799
|
|
|
208,808
|
|
|
969,342
|
|
|
647,193
|
|
Medical office building services costs
|
|
1,569
|
|
|
7,245
|
|
|
9,883
|
|
|
27,082
|
|
General, administrative and professional fees
|
|
23,022
|
|
|
23,527
|
|
|
98,801
|
|
|
74,537
|
|
(Gain) loss on extinguishment of debt, net
|
|
(699
|
)
|
|
2,393
|
|
|
37,640
|
|
|
27,604
|
|
Litigation proceeds, net
|
|
—
|
|
|
(116,932
|
)
|
|
—
|
|
|
(202,259
|
)
|
Merger-related expenses and deal costs
|
|
13,617
|
|
|
22,317
|
|
|
63,183
|
|
|
153,923
|
|
Other
|
|
1,902
|
|
|
1,444
|
|
|
6,956
|
|
|
7,270
|
|
Total expenses
|
|
566,664
|
|
|
377,684
|
|
|
2,205,187
|
|
|
1,412,360
|
|
|
|
|
|
|
|
|
|
|
Income before income/loss from unconsolidated entities, income
taxes, discontinued operations and noncontrolling interest
|
|
94,047
|
|
|
185,461
|
|
|
280,112
|
|
|
331,293
|
|
Income (loss) from unconsolidated entities
|
|
249
|
|
|
19
|
|
|
18,154
|
|
|
(52
|
)
|
Income tax benefit
|
|
3,555
|
|
|
7,622
|
|
|
6,282
|
|
|
30,660
|
|
Income from continuing operations
|
|
97,851
|
|
|
193,102
|
|
|
304,548
|
|
|
361,901
|
|
Discontinued operations
|
|
(11,725
|
)
|
|
(605
|
)
|
|
57,227
|
|
|
1,360
|
|
Net income
|
|
86,126
|
|
|
192,497
|
|
|
361,775
|
|
|
363,261
|
|
Net loss attributable to noncontrolling interest
|
|
(141
|
)
|
|
(451
|
)
|
|
(1,025
|
)
|
|
(1,232
|
)
|
Net income attributable to common stockholders
|
|
$
|
86,267
|
|
|
$
|
192,948
|
|
|
$
|
362,800
|
|
|
$
|
364,493
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share:
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
Income from continuing operations attributable to common
stockholders
|
|
$
|
0.33
|
|
|
$
|
0.67
|
|
|
$
|
1.04
|
|
|
$
|
1.59
|
|
Discontinued operations
|
|
(0.04
|
)
|
|
(0.00
|
)
|
|
0.20
|
|
|
0.01
|
|
Net income attributable to common stockholders
|
|
$
|
0.29
|
|
|
$
|
0.67
|
|
|
$
|
1.24
|
|
|
$
|
1.60
|
|
Diluted:
|
|
|
|
|
|
|
|
|
Income from continuing operations attributable to common
stockholders
|
|
$
|
0.33
|
|
|
$
|
0.66
|
|
|
$
|
1.04
|
|
|
$
|
1.57
|
|
Discontinued operations
|
|
(0.04
|
)
|
|
(0.00
|
)
|
|
0.19
|
|
|
0.01
|
|
Net income attributable to common stockholders
|
|
$
|
0.29
|
|
|
$
|
0.66
|
|
|
$
|
1.23
|
|
|
$
|
1.58
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in computing earnings per common
share:
|
|
|
|
|
|
|
|
|
Basic
|
|
294,704
|
|
|
287,793
|
|
|
292,064
|
|
|
228,453
|
|
Diluted
|
|
297,089
|
|
|
290,607
|
|
|
294,488
|
|
|
230,790
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per common share
|
|
$
|
0.62
|
|
|
$
|
0.575
|
|
|
$
|
2.48
|
|
|
$
|
2.30
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
|
(In thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 Quarters
|
|
|
2011 Fourth
|
|
|
Fourth
|
|
Third
|
|
Second
|
|
First
|
|
|
Quarter
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenues:
|
|
|
|
|
|
|
|
|
|
|
|
Rental income:
|
|
|
|
|
|
|
|
|
|
|
|
Triple-net leased
|
|
$
|
209,922
|
|
|
$
|
209,666
|
|
|
$
|
206,517
|
|
|
$
|
205,116
|
|
|
|
$
|
204,169
|
|
Medical office buildings
|
|
108,951
|
|
|
100,814
|
|
|
89,109
|
|
|
63,965
|
|
|
|
60,008
|
|
|
|
318,873
|
|
|
310,480
|
|
|
295,626
|
|
|
269,081
|
|
|
|
264,177
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Resident fees and services
|
|
322,533
|
|
|
317,131
|
|
|
304,020
|
|
|
285,795
|
|
|
|
277,992
|
|
Medical office building and other services revenue
|
|
3,950
|
|
|
4,544
|
|
|
6,639
|
|
|
5,608
|
|
|
|
10,421
|
|
Income from loans and investments
|
|
14,690
|
|
|
9,035
|
|
|
8,152
|
|
|
8,036
|
|
|
|
9,867
|
|
Interest and other income
|
|
665
|
|
|
330
|
|
|
65
|
|
|
46
|
|
|
|
688
|
|
Total revenues
|
|
660,711
|
|
|
641,520
|
|
|
614,502
|
|
|
568,566
|
|
|
|
563,145
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Interest
|
|
76,700
|
|
|
74,895
|
|
|
73,321
|
|
|
68,485
|
|
|
|
67,443
|
|
Depreciation and amortization
|
|
187,754
|
|
|
189,616
|
|
|
187,783
|
|
|
160,828
|
|
|
|
161,439
|
|
Property-level operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
Senior living
|
|
223,115
|
|
|
216,861
|
|
|
207,548
|
|
|
195,666
|
|
|
|
188,790
|
|
Medical office buildings
|
|
39,684
|
|
|
36,144
|
|
|
29,621
|
|
|
20,703
|
|
|
|
20,018
|
|
|
|
262,799
|
|
|
253,005
|
|
|
237,169
|
|
|
216,369
|
|
|
|
208,808
|
|
Medical office building services costs
|
|
1,569
|
|
|
1,487
|
|
|
3,839
|
|
|
2,988
|
|
|
|
7,245
|
|
General, administrative and professional fees
|
|
23,022
|
|
|
26,872
|
|
|
26,709
|
|
|
22,198
|
|
|
|
23,527
|
|
(Gain) loss on extinguishment of debt, net
|
|
(699
|
)
|
|
(1,194
|
)
|
|
9,989
|
|
|
29,544
|
|
|
|
2,393
|
|
Litigation proceeds, net
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
(116,932
|
)
|
Merger-related expenses and deal costs
|
|
13,617
|
|
|
4,917
|
|
|
36,668
|
|
|
7,981
|
|
|
|
22,317
|
|
Other
|
|
1,902
|
|
|
1,968
|
|
|
1,510
|
|
|
1,576
|
|
|
|
1,444
|
|
Total expenses
|
|
566,664
|
|
|
551,566
|
|
|
576,988
|
|
|
509,969
|
|
|
|
377,684
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income before income from unconsolidated entities, income taxes,
discontinued operations and noncontrolling interest
|
|
94,047
|
|
|
89,954
|
|
|
37,514
|
|
|
58,597
|
|
|
|
185,461
|
|
Income from unconsolidated entities
|
|
249
|
|
|
17,074
|
|
|
514
|
|
|
317
|
|
|
|
19
|
|
Income tax benefit (expense)
|
|
3,555
|
|
|
8,886
|
|
|
5,179
|
|
|
(11,338
|
)
|
|
|
7,622
|
|
Income from continuing operations
|
|
97,851
|
|
|
115,914
|
|
|
43,207
|
|
|
47,576
|
|
|
|
193,102
|
|
Discontinued operations
|
|
(11,725
|
)
|
|
(4,093
|
)
|
|
30,529
|
|
|
42,516
|
|
|
|
(605
|
)
|
Net income
|
|
86,126
|
|
|
111,821
|
|
|
73,736
|
|
|
90,092
|
|
|
|
192,497
|
|
Net loss attributable to noncontrolling interest
|
|
(141
|
)
|
|
(61
|
)
|
|
(289
|
)
|
|
(534
|
)
|
|
|
(451
|
)
|
Net income attributable to common stockholders
|
|
$
|
86,267
|
|
|
$
|
111,882
|
|
|
$
|
74,025
|
|
|
$
|
90,626
|
|
|
|
$
|
192,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations attributable to common
stockholders
|
|
$
|
0.33
|
|
|
$
|
0.39
|
|
|
$
|
0.15
|
|
|
$
|
0.16
|
|
|
|
$
|
0.67
|
|
Discontinued operations
|
|
(0.04
|
)
|
|
(0.01
|
)
|
|
0.11
|
|
|
0.15
|
|
|
|
(0.00
|
)
|
Net income attributable to common stockholders
|
|
$
|
0.29
|
|
|
$
|
0.38
|
|
|
$
|
0.26
|
|
|
$
|
0.31
|
|
|
|
$
|
0.67
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
Income from continuing operations attributable to common
stockholders
|
|
$
|
0.33
|
|
|
$
|
0.39
|
|
|
$
|
0.15
|
|
|
$
|
0.16
|
|
|
|
$
|
0.66
|
|
Discontinued operations
|
|
(0.04
|
)
|
|
(0.01
|
)
|
|
0.10
|
|
|
0.15
|
|
|
|
(0.00
|
)
|
Net income attributable to common stockholders
|
|
$
|
0.29
|
|
|
$
|
0.38
|
|
|
$
|
0.25
|
|
|
$
|
0.31
|
|
|
|
$
|
0.66
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares used in computing earnings per common
share:
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
294,704
|
|
|
294,928
|
|
|
290,170
|
|
|
288,375
|
|
|
|
287,793
|
|
Diluted
|
|
297,089
|
|
|
297,407
|
|
|
292,592
|
|
|
290,813
|
|
|
|
290,607
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
For the years ended December 31, 2012 and 2011
|
(In thousands)
|
|
|
|
2012
|
|
|
2011
|
|
|
|
|
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
Net income
|
|
|
$
|
361,775
|
|
|
|
$
|
363,261
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
Depreciation and amortization (including amounts in discontinued
operations)
|
|
|
764,775
|
|
|
|
459,704
|
|
Amortization of deferred revenue and lease intangibles, net
|
|
|
(17,118
|
)
|
|
|
(12,159
|
)
|
Other non-cash amortization
|
|
|
(39,943
|
)
|
|
|
(13,163
|
)
|
Change in fair value of financial instruments
|
|
|
99
|
|
|
|
2,959
|
|
Stock-based compensation
|
|
|
20,784
|
|
|
|
19,346
|
|
Straight-lining of rental income, net
|
|
|
(24,042
|
)
|
|
|
(14,885
|
)
|
Loss on extinguishment of debt, net
|
|
|
37,640
|
|
|
|
27,604
|
|
Gain on real estate dispositions, net (including amounts in
discontinued operations)
|
|
|
(80,952
|
)
|
|
|
—
|
|
Gain on real estate loan investments
|
|
|
(5,230
|
)
|
|
|
(3,255
|
)
|
Gain on sale of marketable securities
|
|
|
—
|
|
|
|
(733
|
)
|
Income tax benefit (including amounts in discontinued operations)
|
|
|
(6,286
|
)
|
|
|
(31,137
|
)
|
(Income) loss from unconsolidated entities
|
|
|
(1,509
|
)
|
|
|
52
|
|
Gain on re-measurement of equity interest upon acquisition, net
|
|
|
(16,645
|
)
|
|
|
—
|
|
Other
|
|
|
10,315
|
|
|
|
4,446
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
Decrease in other assets
|
|
|
3,756
|
|
|
|
424
|
|
Increase (decrease) in accrued interest
|
|
|
9,969
|
|
|
|
(9,150
|
)
|
Decrease in accounts payable and other liabilities
|
|
|
(24,572
|
)
|
|
|
(20,117
|
)
|
Net cash provided by operating activities
|
|
|
992,816
|
|
|
|
773,197
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
Net investment in real estate
|
|
|
(1,453,065
|
)
|
|
|
(531,605
|
)
|
Purchase of private investment funds
|
|
|
(276,419
|
)
|
|
|
—
|
|
Purchase of noncontrolling interest
|
|
|
(3,934
|
)
|
|
|
(3,319
|
)
|
Investment in loans receivable
|
|
|
(452,558
|
)
|
|
|
(628,133
|
)
|
Proceeds from real estate disposals
|
|
|
149,045
|
|
|
|
20,618
|
|
Proceeds from loans receivable
|
|
|
43,219
|
|
|
|
220,179
|
|
Proceeds from sale or maturity of marketable securities
|
|
|
37,500
|
|
|
|
23,050
|
|
Funds held in escrow for future development expenditures
|
|
|
(28,050
|
)
|
|
|
—
|
|
Development project expenditures
|
|
|
(114,002
|
)
|
|
|
(47,591
|
)
|
Capital expenditures
|
|
|
(69,430
|
)
|
|
|
(50,473
|
)
|
Other
|
|
|
(1,995
|
)
|
|
|
(165
|
)
|
Net cash used in investing activities
|
|
|
(2,169,689
|
)
|
|
|
(997,439
|
)
|
Cash flows from financing activities:
|
|
|
|
|
|
|
Net change in borrowings under revolving credit facilities
|
|
|
84,938
|
|
|
|
537,452
|
|
Proceeds from debt
|
|
|
2,710,405
|
|
|
|
1,343,640
|
|
Repayment of debt
|
|
|
(1,193,023
|
)
|
|
|
(1,388,962
|
)
|
Payment of deferred financing costs
|
|
|
(23,770
|
)
|
|
|
(20,040
|
)
|
Issuance of common stock, net
|
|
|
342,469
|
|
|
|
299,847
|
|
Cash distribution to common stockholders
|
|
|
(728,546
|
)
|
|
|
(521,046
|
)
|
Cash distribution to redeemable OP unitholders
|
|
|
(4,446
|
)
|
|
|
(2,359
|
)
|
Purchases of redeemable OP units
|
|
|
(4,601
|
)
|
|
|
(185
|
)
|
Distributions to noncontrolling interest
|
|
|
(5,215
|
)
|
|
|
(2,556
|
)
|
Other
|
|
|
20,703
|
|
|
|
2,491
|
|
Net cash provided by financing activities
|
|
|
1,198,914
|
|
|
|
248,282
|
|
Net increase in cash and cash equivalents
|
|
|
22,041
|
|
|
|
24,040
|
|
Effect of foreign currency translation on cash and cash equivalents
|
|
|
60
|
|
|
|
(45
|
)
|
Cash and cash equivalents at beginning of period
|
|
|
45,807
|
|
|
|
21,812
|
|
Cash and cash equivalents at end of period
|
|
|
$
|
67,908
|
|
|
|
$
|
45,807
|
|
|
|
|
|
|
|
|
Supplemental schedule of non-cash activities:
|
|
|
|
|
|
|
Assets and liabilities assumed from acquisitions:
|
|
|
|
|
|
|
Real estate investments
|
|
|
$
|
582,694
|
|
|
|
$
|
10,973,093
|
|
Utilization of funds held for an Internal Revenue Code Section 1031
exchange
|
|
|
(134,003
|
)
|
|
|
—
|
|
Other assets acquired
|
|
|
77,730
|
|
|
|
594,176
|
|
Debt assumed
|
|
|
412,825
|
|
|
|
3,651,089
|
|
Other liabilities
|
|
|
70,391
|
|
|
|
952,279
|
|
Deferred income tax liability
|
|
|
4,299
|
|
|
|
43,889
|
|
Redeemable OP unitholder interests
|
|
|
—
|
|
|
|
100,888
|
|
Noncontrolling interests
|
|
|
34,580
|
|
|
|
81,192
|
|
Equity issued
|
|
|
4,326
|
|
|
|
6,737,932
|
|
Debt transferred on the sale of assets
|
|
|
14,535
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(In thousands)
|
|
|
2012 Quarters
|
|
|
2011 Fourth
|
|
|
Fourth
|
|
Third
|
|
Second
|
|
First
|
|
|
Quarter
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
86,126
|
|
|
$
|
111,821
|
|
|
$
|
73,736
|
|
|
$
|
90,092
|
|
|
|
$
|
192,497
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization (including amounts in discontinued
operations)
|
|
201,748
|
|
|
196,622
|
|
|
201,769
|
|
|
164,636
|
|
|
|
166,163
|
|
Amortization of deferred revenue and lease intangibles, net
|
|
(4,153
|
)
|
|
(4,136
|
)
|
|
(3,669
|
)
|
|
(5,160
|
)
|
|
|
(4,701
|
)
|
Other non-cash amortization
|
|
(8,617
|
)
|
|
(10,141
|
)
|
|
(11,077
|
)
|
|
(10,108
|
)
|
|
|
(7,734
|
)
|
Change in fair value of financial instruments
|
|
(52
|
)
|
|
58
|
|
|
60
|
|
|
33
|
|
|
|
61
|
|
Stock-based compensation
|
|
4,255
|
|
|
5,443
|
|
|
6,252
|
|
|
4,834
|
|
|
|
5,750
|
|
Straight-lining of rental income, net
|
|
(7,330
|
)
|
|
(6,242
|
)
|
|
(5,580
|
)
|
|
(4,890
|
)
|
|
|
(5,631
|
)
|
(Gain) loss on extinguishment of debt, net
|
|
(699
|
)
|
|
(1,194
|
)
|
|
9,989
|
|
|
29,544
|
|
|
|
2,393
|
|
Gain on real estate dispositions, net (including amounts in
discontinued operations)
|
|
(1,804
|
)
|
|
(357
|
)
|
|
(38,558
|
)
|
|
(40,233
|
)
|
|
|
—
|
|
(Gain) loss on real estate loan investments
|
|
(5,789
|
)
|
|
—
|
|
|
—
|
|
|
559
|
|
|
|
—
|
|
Income tax (benefit) expense (including amounts in discontinued
operations)
|
|
(3,555
|
)
|
|
(8,870
|
)
|
|
(5,166
|
)
|
|
11,305
|
|
|
|
(7,827
|
)
|
Income from unconsolidated entities
|
|
(249
|
)
|
|
(429
|
)
|
|
(514
|
)
|
|
(317
|
)
|
|
|
(19
|
)
|
Gain on re-measurement of equity interest upon acquisition, net
|
|
—
|
|
|
(16,645
|
)
|
|
—
|
|
|
—
|
|
|
|
—
|
|
Other
|
|
3,994
|
|
|
424
|
|
|
2,848
|
|
|
3,049
|
|
|
|
2,442
|
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
Decrease (increase) in other assets
|
|
15,686
|
|
|
(12,791
|
)
|
|
(414
|
)
|
|
1,275
|
|
|
|
27,433
|
|
(Decrease) increase in accrued interest
|
|
(8,761
|
)
|
|
8,471
|
|
|
(10,193
|
)
|
|
20,452
|
|
|
|
(28,291
|
)
|
Increase (decrease) in accounts payable and other liabilities
|
|
12,697
|
|
|
(13,524
|
)
|
|
(3,635
|
)
|
|
(20,110
|
)
|
|
|
(13,240
|
)
|
Net cash provided by operating activities
|
|
283,497
|
|
|
248,510
|
|
|
215,848
|
|
|
244,961
|
|
|
|
329,296
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
Net investment in real estate property
|
|
(298,153
|
)
|
|
(255,508
|
)
|
|
(898,904
|
)
|
|
(500
|
)
|
|
|
(186,918
|
)
|
Purchase of private investment funds
|
|
(276,419
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
Purchase of noncontrolling interest
|
|
—
|
|
|
—
|
|
|
(3,934
|
)
|
|
—
|
|
|
|
—
|
|
Investment in loans receivable
|
|
(422,035
|
)
|
|
(3,263
|
)
|
|
(4,787
|
)
|
|
(22,473
|
)
|
|
|
(8,274
|
)
|
Proceeds from sale or maturity of marketable securities
|
|
37,500
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
Proceeds from real estate disposals
|
|
73,900
|
|
|
66,298
|
|
|
—
|
|
|
8,847
|
|
|
|
5,657
|
|
Proceeds from loans receivable
|
|
8,402
|
|
|
1,594
|
|
|
15,979
|
|
|
17,244
|
|
|
|
81,245
|
|
Funds held in escrow for future development expenditures
|
|
(28,050
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
—
|
|
Development project expenditures
|
|
(23,883
|
)
|
|
(29,558
|
)
|
|
(29,287
|
)
|
|
(31,274
|
)
|
|
|
(24,358
|
)
|
Capital expenditures
|
|
(27,160
|
)
|
|
(18,458
|
)
|
|
(13,793
|
)
|
|
(10,019
|
)
|
|
|
(21,815
|
)
|
Other
|
|
115
|
|
|
40
|
|
|
(13
|
)
|
|
(2,137
|
)
|
|
|
(52
|
)
|
Net cash used in investing activities
|
|
(955,783
|
)
|
|
(238,855
|
)
|
|
(934,739
|
)
|
|
(40,312
|
)
|
|
|
(154,515
|
)
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
Net change in borrowings under revolving credit facilities
|
|
(163,983
|
)
|
|
337,575
|
|
|
293,744
|
|
|
(382,398
|
)
|
|
|
103,452
|
|
Proceeds from debt
|
|
1,142,023
|
|
|
299,067
|
|
|
601,985
|
|
|
667,330
|
|
|
|
385,887
|
|
Repayment of debt
|
|
(90,023
|
)
|
|
(457,278
|
)
|
|
(346,921
|
)
|
|
(298,801
|
)
|
|
|
(493,919
|
)
|
Payment of deferred financing costs
|
|
(19,513
|
)
|
|
(1,277
|
)
|
|
(1,187
|
)
|
|
(1,793
|
)
|
|
|
(18,142
|
)
|
Issuance of common stock, net
|
|
—
|
|
|
—
|
|
|
342,469
|
|
|
—
|
|
|
|
(79
|
)
|
Cash distribution to common stockholders
|
|
(183,306
|
)
|
|
(183,283
|
)
|
|
(182,704
|
)
|
|
(179,253
|
)
|
|
|
(166,114
|
)
|
Cash distribution to redeemable OP unitholders
|
|
(1,088
|
)
|
|
(1,117
|
)
|
|
(1,129
|
)
|
|
(1,112
|
)
|
|
|
1,679
|
|
Purchases of redeemable OP units
|
|
(2,841
|
)
|
|
(1,149
|
)
|
|
(378
|
)
|
|
(233
|
)
|
|
|
(185
|
)
|
Distributions to noncontrolling interest
|
|
(1,180
|
)
|
|
(1,128
|
)
|
|
(1,315
|
)
|
|
(1,592
|
)
|
|
|
(559
|
)
|
Other
|
|
1,573
|
|
|
4,621
|
|
|
13,944
|
|
|
565
|
|
|
|
1,472
|
|
Net cash provided by (used in) financing activities
|
|
681,662
|
|
|
(3,969
|
)
|
|
718,508
|
|
|
(197,287
|
)
|
|
|
(186,508
|
)
|
Net increase (decrease) in cash and cash equivalents
|
|
9,376
|
|
|
5,686
|
|
|
(383
|
)
|
|
7,362
|
|
|
|
(11,727
|
)
|
Effect of foreign currency translation on cash and cash equivalents
|
|
2
|
|
|
40
|
|
|
(37
|
)
|
|
55
|
|
|
|
52
|
|
Cash and cash equivalents at beginning of period
|
|
58,530
|
|
|
52,804
|
|
|
53,224
|
|
|
45,807
|
|
|
|
57,482
|
|
Cash and cash equivalents at end of period
|
|
$
|
67,908
|
|
|
$
|
58,530
|
|
|
$
|
52,804
|
|
|
$
|
53,224
|
|
|
|
$
|
45,807
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental schedule of non-cash activities:
|
|
|
|
|
|
|
|
|
|
|
|
Assets and liabilities assumed from acquisitions:
|
|
|
|
|
|
|
|
|
|
|
|
Real estate investments
|
|
$
|
84,939
|
|
|
$
|
132,872
|
|
|
$
|
310,002
|
|
|
$
|
54,881
|
|
|
|
$
|
(61,527
|
)
|
Utilization of funds held for an Internal Revenue Code Section 1031
exchange
|
|
—
|
|
|
—
|
|
|
(96,204
|
)
|
|
(37,799
|
)
|
|
|
—
|
|
Other assets acquired
|
|
(22,159
|
)
|
|
18,380
|
|
|
86,635
|
|
|
(5,126
|
)
|
|
|
162,497
|
|
Debt assumed
|
|
44,923
|
|
|
117,539
|
|
|
232,629
|
|
|
17,734
|
|
|
|
142,863
|
|
Other liabilities
|
|
9,707
|
|
|
34,045
|
|
|
33,628
|
|
|
(6,989
|
)
|
|
|
(39,843
|
)
|
Deferred income tax liability
|
|
—
|
|
|
(1,596
|
)
|
|
5,895
|
|
|
—
|
|
|
|
—
|
|
Redeemable OP unitholder interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
458
|
|
Noncontrolling interests
|
|
8,150
|
|
|
1,264
|
|
|
28,281
|
|
|
(3,115
|
)
|
|
|
(2,510
|
)
|
Equity issued
|
|
—
|
|
|
—
|
|
|
—
|
|
|
4,326
|
|
|
|
2
|
|
Debt transferred on the sale of assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,535
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Funds From Operations (FFO) Reconciliation Including Non-Cash
Items1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year-Over-Year
|
|
Tentative Estimates Preliminary and Subject
to Change
|
|
Year-Over-Year
|
|
|
2011
|
|
2012
|
|
Growth
|
|
FY2013 - Guidance
|
|
Growth2
|
|
|
Q4
|
|
FY
|
|
Q1
|
|
Q2
|
|
Q3
|
|
Q4
|
|
FY
|
|
'11-'12
|
|
Low
|
|
High
|
|
'12-'13E
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income attributable to common stockholders
|
|
$
|
192,948
|
|
|
$
|
364,493
|
|
|
$
|
90,626
|
|
|
$
|
74,025
|
|
|
$
|
111,882
|
|
|
$
|
86,267
|
|
|
$
|
362,800
|
|
|
|
|
$
|
389,013
|
|
|
$
|
466,182
|
|
|
|
Net income attributable to common stockholders per share
|
|
$
|
0.66
|
|
|
$
|
1.58
|
|
|
$
|
0.31
|
|
|
$
|
0.25
|
|
|
$
|
0.38
|
|
|
$
|
0.29
|
|
|
$
|
1.23
|
|
|
|
|
$
|
1.32
|
|
|
$
|
1.59
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization on real estate assets
|
|
|
160,805
|
|
|
|
445,237
|
|
|
|
159,926
|
|
|
|
186,782
|
|
|
|
188,364
|
|
|
|
186,486
|
|
|
|
721,558
|
|
|
|
|
|
733,848
|
|
|
|
723,848
|
|
|
|
Depreciation on real estate assets related to noncontrolling
interest
|
|
|
(1,744
|
)
|
|
|
(3,471
|
)
|
|
|
(1,511
|
)
|
|
|
(2,336
|
)
|
|
|
(2,221
|
)
|
|
|
(2,435
|
)
|
|
|
(8,503
|
)
|
|
|
|
|
(8,768
|
)
|
|
|
(10,768
|
)
|
|
|
Depreciation on real estate assets related to unconsolidated
entities
|
|
|
2,339
|
|
|
|
6,552
|
|
|
|
2,175
|
|
|
|
2,131
|
|
|
|
1,700
|
|
|
|
1,510
|
|
|
|
7,516
|
|
|
|
|
|
5,771
|
|
|
|
4,771
|
|
|
|
Gain on re-measurement of equity interest upon acquisition, net
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(16,645
|
)
|
|
|
-
|
|
|
|
(16,645
|
)
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
Discontinued operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain on real estate dispositions, net
|
|
|
-
|
|
|
|
-
|
|
|
|
(40,233
|
)
|
|
|
(38,558
|
)
|
|
|
(357
|
)
|
|
|
(1,804
|
)
|
|
|
(80,952
|
)
|
|
|
|
|
6,783
|
|
|
|
783
|
|
|
|
Depreciation and amortization on real estate assets
|
|
|
4,724
|
|
|
|
12,040
|
|
|
|
3,808
|
|
|
|
13,986
|
|
|
|
7,006
|
|
|
|
13,993
|
|
|
|
38,793
|
|
|
|
|
|
9,431
|
|
|
|
9,431
|
|
|
|
Subtotal: Funds From Operations add-backs
|
|
|
166,124
|
|
|
|
460,358
|
|
|
|
124,165
|
|
|
|
162,005
|
|
|
|
177,847
|
|
|
|
197,750
|
|
|
|
661,767
|
|
|
|
|
|
747,065
|
|
|
|
728,065
|
|
|
|
Subtotal: Funds From Operations add-backs per share
|
|
$
|
0.57
|
|
|
$
|
1.99
|
|
|
$
|
0.43
|
|
|
$
|
0.55
|
|
|
$
|
0.60
|
|
|
$
|
0.67
|
|
|
$
|
2.25
|
|
|
|
|
$
|
2.54
|
|
|
$
|
2.48
|
|
|
|
Funds From Operations
|
|
$
|
359,072
|
|
|
$
|
824,851
|
|
|
$
|
214,791
|
|
|
$
|
236,030
|
|
|
$
|
289,729
|
|
|
$
|
284,017
|
|
|
$
|
1,024,567
|
|
|
24
|
%
|
|
$
|
1,136,078
|
|
|
$
|
1,194,247
|
|
|
14
|
%
|
Funds From Operations per share
|
|
$
|
1.23
|
|
|
$
|
3.57
|
|
|
$
|
0.74
|
|
|
$
|
0.81
|
|
|
$
|
0.97
|
|
|
$
|
0.96
|
|
|
$
|
3.48
|
|
|
(3
|
)%
|
|
$
|
3.87
|
|
|
$
|
4.07
|
|
|
14
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Merger-related expenses and deal costs
|
|
|
22,317
|
|
|
|
153,923
|
|
|
|
7,981
|
|
|
|
36,668
|
|
|
|
4,917
|
|
|
|
13,617
|
|
|
|
63,183
|
|
|
|
|
|
20,675
|
|
|
|
-
|
|
|
|
Income tax (benefit) expense
|
|
|
(7,827
|
)
|
|
|
(31,137
|
)
|
|
|
11,305
|
|
|
|
(5,166
|
)
|
|
|
(8,870
|
)
|
|
|
(3,555
|
)
|
|
|
(6,286
|
)
|
|
|
|
|
8,500
|
|
|
|
5,500
|
|
|
|
Loss (gain) on extinguishment of debt, net
|
|
|
2,393
|
|
|
|
27,604
|
|
|
|
29,544
|
|
|
|
9,989
|
|
|
|
(1,194
|
)
|
|
|
(699
|
)
|
|
|
37,640
|
|
|
|
|
|
5,000
|
|
|
|
(5,000
|
)
|
|
|
Litigation proceeds, net
|
|
|
(116,932
|
)
|
|
|
(202,259
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
Change in fair value of financial instruments
|
|
|
61
|
|
|
|
2,959
|
|
|
|
33
|
|
|
|
60
|
|
|
|
58
|
|
|
|
(52
|
)
|
|
|
99
|
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
Amortization of other intangibles
|
|
|
255
|
|
|
|
1,022
|
|
|
|
256
|
|
|
|
255
|
|
|
|
256
|
|
|
|
255
|
|
|
|
1,022
|
|
|
|
|
|
1,522
|
|
|
|
522
|
|
|
|
Subtotal: Normalized Funds From Operations add-backs
|
|
|
(99,733
|
)
|
|
|
(47,888
|
)
|
|
|
49,119
|
|
|
|
41,806
|
|
|
|
(4,833
|
)
|
|
|
9,566
|
|
|
|
95,658
|
|
|
|
|
|
35,697
|
|
|
|
1,022
|
|
|
|
Subtotal: Normalized Funds From Operations add-backs per share
|
|
$
|
(0.34
|
)
|
|
$
|
(0.21
|
)
|
|
$
|
0.17
|
|
|
$
|
0.14
|
|
|
$
|
(0.02
|
)
|
|
$
|
0.03
|
|
|
$
|
0.32
|
|
|
|
|
$
|
0.12
|
|
|
$
|
0.00
|
|
|
|
Normalized Funds From Operations
|
|
$
|
259,339
|
|
|
$
|
776,963
|
|
|
$
|
263,910
|
|
|
$
|
277,836
|
|
|
$
|
284,896
|
|
|
$
|
293,583
|
|
|
$
|
1,120,225
|
|
|
44
|
%
|
|
$
|
1,171,775
|
|
|
$
|
1,195,270
|
|
|
6
|
%
|
Normalized Funds From Operations per share
|
|
$
|
0.89
|
|
|
$
|
3.37
|
|
|
$
|
0.91
|
|
|
$
|
0.95
|
|
|
$
|
0.96
|
|
|
$
|
0.99
|
|
|
$
|
3.80
|
|
|
13
|
%
|
|
$
|
3.99
|
|
|
$
|
4.07
|
|
|
6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-cash items included in Normalized FFO:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of deferred revenue and lease intangibles, net
|
|
|
(4,701
|
)
|
|
|
(12,159
|
)
|
|
|
(5,160
|
)
|
|
|
(3,669
|
)
|
|
|
(4,136
|
)
|
|
|
(4,153
|
)
|
|
|
(17,118
|
)
|
|
|
|
|
(16,290
|
)
|
|
|
(16,290
|
)
|
|
|
Other non-cash amortization, including fair market value of debt
|
|
|
(7,734
|
)
|
|
|
(13,163
|
)
|
|
|
(10,108
|
)
|
|
|
(11,077
|
)
|
|
|
(10,141
|
)
|
|
|
(8,617
|
)
|
|
|
(39,943
|
)
|
|
|
|
|
(19,055
|
)
|
|
|
(19,055
|
)
|
|
|
Stock-based compensation
|
|
|
5,750
|
|
|
|
19,346
|
|
|
|
4,834
|
|
|
|
6,252
|
|
|
|
5,443
|
|
|
|
4,255
|
|
|
|
20,784
|
|
|
|
|
|
19,460
|
|
|
|
19,460
|
|
|
|
Straight-lining of rental income, net
|
|
|
(5,631
|
)
|
|
|
(14,885
|
)
|
|
|
(4,890
|
)
|
|
|
(5,580
|
)
|
|
|
(6,242
|
)
|
|
|
(7,330
|
)
|
|
|
(24,042
|
)
|
|
|
|
|
(19,758
|
)
|
|
|
(19,758
|
)
|
|
|
Subtotal: non-cash items included in Normalized FFO
|
|
|
(12,316
|
)
|
|
|
(20,861
|
)
|
|
|
(15,324
|
)
|
|
|
(14,073
|
)
|
|
|
(15,076
|
)
|
|
|
(15,846
|
)
|
|
|
(60,318
|
)
|
|
|
|
|
(35,642
|
)
|
|
|
(35,642
|
)
|
|
|
Subtotal: non-cash items included in Normalized FFO per share
|
|
$
|
(0.04
|
)
|
|
$
|
(0.09
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.20
|
)
|
|
|
|
$
|
(0.12
|
)
|
|
$
|
(0.12
|
)
|
|
|
Normalized FFO, excluding non-cash items
|
|
$
|
247,023
|
|
|
$
|
756,102
|
|
|
$
|
248,586
|
|
|
$
|
263,763
|
|
|
$
|
269,820
|
|
|
$
|
277,737
|
|
|
$
|
1,059,907
|
|
|
40
|
%
|
|
$
|
1,136,133
|
|
|
$
|
1,159,627
|
|
|
8
|
%
|
Normalized FFO, excluding non-cash items per share
|
|
$
|
0.85
|
|
|
$
|
3.28
|
|
|
$
|
0.85
|
|
|
$
|
0.90
|
|
|
$
|
0.91
|
|
|
$
|
0.93
|
|
|
$
|
3.60
|
|
|
10
|
%
|
|
$
|
3.87
|
|
|
$
|
3.95
|
|
|
9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average diluted shares
|
|
|
290,813
|
|
|
|
230,790
|
|
|
|
290,813
|
|
|
|
292,592
|
|
|
|
297,407
|
|
|
|
297,089
|
|
|
|
294,488
|
|
|
|
|
|
293,678
|
|
|
|
293,678
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 In thousands, except per share amounts.
Totals and per share amounts may not add due to rounding. Per
share quarterly amounts may not add to annual per share amounts
due to material changes in the Company's weighted average diluted
share count, if any.
|
2 2012-2013 growth assumes the midpoint of
2013 Guidance.
|
Historical cost accounting for real estate assets implicitly assumes
that the value of real estate assets diminishes predictably over time.
Since real estate values instead have historically risen or fallen with
market conditions, many industry investors have considered presentations
of operating results for real estate companies that use historical cost
accounting to be insufficient by themselves. To overcome this problem,
the Company considers FFO and normalized FFO appropriate measures of
operating performance of an equity REIT. Moreover, the Company believes
that normalized FFO provides useful information because it allows
investors, analysts and Company management to compare the Company's
operating performance to the operating performance of other real estate
companies and between periods on a consistent basis without having to
account for differences caused by unanticipated items such as
transactions and litigation.
The Company uses the NAREIT definition of FFO. NAREIT defines FFO as net
income, computed in accordance with GAAP, excluding gains (or losses)
from sales of real estate property, including gain on re-measurement of
equity method investments, and impairment write-downs of depreciable
real estate, plus real estate depreciation and amortization and after
adjustments for unconsolidated partnerships and joint ventures.
Adjustments for unconsolidated partnerships and joint ventures will be
calculated to reflect FFO on the same basis. The Company defines
normalized FFO as FFO excluding the following income and expense items
(which may be recurring in nature): (a) net gains on real estate
activity; (b) merger-related costs and expenses, including amortization
of intangibles and transition and integration expenses, and deal costs
and expenses, including expenses and recoveries relating to the
Company's lawsuit against HCP, Inc.; (c) the impact of any expenses
related to asset impairment and valuation allowances, the write-off of
unamortized deferred financing fees, or additional costs, expenses,
discounts, make-whole payments, penalties or premiums incurred as a
result of early retirement or payment of the Company's debt; (d) the
non-cash effect of income tax benefits or expenses; (e) the impact of
future acquisitions or divestitures (including pursuant to tenant
options to purchase) and capital transactions; (f) the financial impact
of contingent consideration; (g) charitable donations made to the Ventas
Charitable Foundation; and (h) gains and losses for non-operational
foreign currency hedge agreements and changes in the fair value of
financial instruments.
FFO and normalized FFO presented herein may not be identical to FFO and
normalized FFO presented by other real estate companies due to the fact
that not all real estate companies use the same definitions. FFO and
normalized FFO should not be considered as alternatives to net income
(determined in accordance with GAAP) as indicators of the Company's
financial performance or as alternatives to cash flow from operating
activities (determined in accordance with GAAP) as measures of the
Company's liquidity, nor are FFO and normalized FFO necessarily
indicative of sufficient cash flow to fund all of the Company's needs.
The Company believes that in order to facilitate a clear understanding
of the consolidated historical operating results of the Company, FFO and
normalized FFO should be examined in conjunction with net income as
presented elsewhere herein.
Non-GAAP Financial Measures Reconciliation
Net Debt to
Adjusted Pro Forma EBITDA
The following information considers the pro forma effect on net income,
interest and depreciation of the Company's investments and other capital
transactions that were completed during the three months ended December
31, 2012, as if the transactions had been consummated as of the
beginning of the period. The following table illustrates net debt to pro
forma earnings before interest, taxes, depreciation and amortization
(including non-cash stock-based compensation expense), excluding gain on
extinguishment of debt, merger-related expenses and deal costs, net
gains on real estate activity and changes in the fair value of financial
instruments (including amounts in discontinued operations) (“Adjusted
Pro Forma EBITDA”) (dollars in thousands):
|
|
|
|
|
Net income attributable to common stockholders
|
|
$
|
86,267
|
|
Pro forma adjustments for current period investments, capital
transactions and dispositions
|
|
(1,567
|
)
|
Pro forma net income for the three months ended December 31, 2012
|
|
84,700
|
|
Add back:
|
|
|
Pro forma interest (including discontinued operations)
|
|
82,423
|
|
Pro forma depreciation and amortization (including discontinued
operations)
|
|
203,502
|
|
Stock-based compensation
|
|
4,255
|
|
Gain on extinguishment of debt, net
|
|
(699
|
)
|
Gain on real estate dispositions, net
|
|
(1,804
|
)
|
Income tax benefit (including discontinued operations)
|
|
(3,555
|
)
|
Change in fair value of financial instruments
|
|
(52
|
)
|
Other taxes
|
|
790
|
|
Merger-related expenses and deal costs
|
|
13,617
|
|
Adjusted Pro Forma EBITDA
|
|
$
|
383,177
|
|
Adjusted Pro Forma EBITDA annualized
|
|
$
|
1,532,708
|
|
|
|
|
|
|
|
As of December 31, 2012:
|
|
|
Debt
|
|
$
|
8,413,646
|
|
Cash, including cash escrows pertaining to debt
|
|
(111,635
|
)
|
Net debt
|
|
$
|
8,302,011
|
|
|
|
|
Net debt to Adjusted Pro Forma EBITDA
|
|
5.4x
|
|
Non-GAAP Financial Measures Reconciliation
|
NOI Reconciliation by Segment
|
(In thousands)
|
|
|
2012 Quarters
|
|
2011 Fourth
|
|
|
Fourth
|
|
Third
|
|
Second
|
|
First
|
|
Quarter
|
Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Triple-Net
|
|
|
|
|
|
|
|
|
|
|
Triple-Net Rental Income
|
|
$
|
209,922
|
|
|
$
|
209,666
|
|
|
$
|
206,517
|
|
|
$
|
205,116
|
|
|
$
|
204,169
|
|
|
|
|
|
|
|
|
|
|
|
Medical Office Buildings
|
|
|
|
|
|
|
|
|
|
|
Medical Office - Stabilized
|
|
100,027
|
|
|
92,458
|
|
|
80,335
|
|
|
56,251
|
|
|
53,826
|
Medical Office - Lease up
|
|
8,924
|
|
|
8,356
|
|
|
8,774
|
|
|
7,714
|
|
|
6,182
|
Total Medical Office Buildings - Rental Income
|
|
108,951
|
|
|
100,814
|
|
|
89,109
|
|
|
63,965
|
|
|
60,008
|
Total Rental Income
|
|
318,873
|
|
|
310,480
|
|
|
295,626
|
|
|
269,081
|
|
|
264,177
|
|
|
|
|
|
|
|
|
|
|
|
Medical Office Building Services Revenue
|
|
2,840
|
|
|
3,434
|
|
|
5,529
|
|
|
4,499
|
|
|
9,313
|
Total Medical Office Buildings - Revenue
|
|
111,791
|
|
|
104,248
|
|
|
94,638
|
|
|
68,464
|
|
|
69,321
|
|
|
|
|
|
|
|
|
|
|
|
Triple-Net Services Revenue
|
|
1,110
|
|
|
1,110
|
|
|
1,110
|
|
|
1,109
|
|
|
1,108
|
Total Medical Office Building and Other Services Revenue
|
|
3,950
|
|
|
4,544
|
|
|
6,639
|
|
|
5,608
|
|
|
10,421
|
|
|
|
|
|
|
|
|
|
|
|
Seniors Housing Operating
|
|
|
|
|
|
|
|
|
|
|
Seniors Housing - Stabilized
|
|
309,252
|
|
|
296,508
|
|
|
283,214
|
|
|
271,396
|
|
|
264,860
|
Seniors Housing - Lease up
|
|
11,940
|
|
|
19,311
|
|
|
19,491
|
|
|
13,078
|
|
|
11,866
|
Seniors Housing - Other
|
|
1,341
|
|
|
1,312
|
|
|
1,315
|
|
|
1,321
|
|
|
1,266
|
Total Resident Fees and Services
|
|
322,533
|
|
|
317,131
|
|
|
304,020
|
|
|
285,795
|
|
|
277,992
|
|
|
|
|
|
|
|
|
|
|
|
Non-Segment Income from Loans and Investments
|
|
14,690
|
|
|
9,035
|
|
|
8,152
|
|
|
8,036
|
|
|
9,867
|
Total Revenues, excluding Interest and Other Income
|
|
660,046
|
|
|
641,190
|
|
|
614,437
|
|
|
568,520
|
|
|
562,457
|
|
|
|
|
|
|
|
|
|
|
|
Property-Level Operating Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Medical Office Buildings
|
|
|
|
|
|
|
|
|
|
|
Medical Office - Stabilized
|
|
36,360
|
|
|
32,981
|
|
|
26,401
|
|
|
17,845
|
|
|
17,649
|
Medical Office - Lease up
|
|
3,324
|
|
|
3,163
|
|
|
3,220
|
|
|
2,858
|
|
|
2,369
|
Total Medical Office Buildings
|
|
39,684
|
|
|
36,144
|
|
|
29,621
|
|
|
20,703
|
|
|
20,018
|
|
|
|
|
|
|
|
|
|
|
|
Seniors Housing Operating
|
|
|
|
|
|
|
|
|
|
|
Seniors Housing - Stabilized
|
|
212,781
|
|
|
202,045
|
|
|
192,640
|
|
|
184,748
|
|
|
177,890
|
Seniors Housing - Lease up
|
|
9,191
|
|
|
13,631
|
|
|
13,786
|
|
|
9,795
|
|
|
9,803
|
Seniors Housing - Other
|
|
1,143
|
|
|
1,185
|
|
|
1,122
|
|
|
1,123
|
|
|
1,097
|
Total Seniors Housing
|
|
223,115
|
|
|
216,861
|
|
|
207,548
|
|
|
195,666
|
|
|
188,790
|
Total Property-Level Operating Expenses
|
|
262,799
|
|
|
253,005
|
|
|
237,169
|
|
|
216,369
|
|
|
208,808
|
|
|
|
|
|
|
|
|
|
|
|
Medical Office Building Services Costs
|
|
1,569
|
|
|
1,487
|
|
|
3,839
|
|
|
2,988
|
|
|
7,245
|
|
|
|
|
|
|
|
|
|
|
|
Net Operating Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Triple-Net
|
|
|
|
|
|
|
|
|
|
|
Triple-Net Properties
|
|
209,922
|
|
|
209,666
|
|
|
206,517
|
|
|
205,116
|
|
|
204,169
|
Triple-Net Services Revenue
|
|
1,110
|
|
|
1,110
|
|
|
1,110
|
|
|
1,109
|
|
|
1,108
|
Total Triple-Net
|
|
211,032
|
|
|
210,776
|
|
|
207,627
|
|
|
206,225
|
|
|
205,277
|
|
|
|
|
|
|
|
|
|
|
|
Medical Office Buildings
|
|
|
|
|
|
|
|
|
|
|
Medical Office - Stabilized
|
|
63,667
|
|
|
59,477
|
|
|
53,934
|
|
|
38,406
|
|
|
36,177
|
Medical Office - Lease up
|
|
5,600
|
|
|
5,193
|
|
|
5,554
|
|
|
4,856
|
|
|
3,813
|
Medical Office Buildings Services
|
|
1,271
|
|
|
1,947
|
|
|
1,690
|
|
|
1,511
|
|
|
2,068
|
Total Medical Office Buildings
|
|
70,538
|
|
|
66,617
|
|
|
61,178
|
|
|
44,773
|
|
|
42,058
|
|
|
|
|
|
|
|
|
|
|
|
Seniors Housing Operating
|
|
|
|
|
|
|
|
|
|
|
Seniors Housing - Stabilized
|
|
96,471
|
|
|
94,463
|
|
|
90,574
|
|
|
86,648
|
|
|
86,970
|
Seniors Housing - Lease up
|
|
2,749
|
|
|
5,680
|
|
|
5,705
|
|
|
3,283
|
|
|
2,063
|
Seniors Housing - Other
|
|
198
|
|
|
127
|
|
|
193
|
|
|
198
|
|
|
169
|
Total Seniors Housing
|
|
99,418
|
|
|
100,270
|
|
|
96,472
|
|
|
90,129
|
|
|
89,202
|
Non-Segment
|
|
14,690
|
|
|
9,035
|
|
|
8,152
|
|
|
8,036
|
|
|
9,867
|
Net Operating Income
|
|
$
|
395,678
|
|
|
$
|
386,698
|
|
|
$
|
373,429
|
|
|
$
|
349,163
|
|
|
$
|
346,404
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note: Amounts above are adjusted to exclude discontinued operations
for all periods presented.
|
Non-GAAP Financial Measures Reconciliation
Annual NOI
The Company believes that NOI and same-store NOI provide useful
information because those disclosures allow investors, analysts and
Company management to measure unlevered property-level operating results
and to compare the Company's operating results to the operating results
of other real estate companies and between periods on a consistent
basis. Those terms are commonly used in evaluating results of real
estate companies. The Company defines NOI as total revenues, excluding
interest and other income, less property-level operating expenses and
medical office building services costs (including amounts in
discontinued operations). The following is a reconciliation of NOI to
net income (including amounts in discontinued operations) for the years
ended December 31, 2012 and 2011 (in thousands):
|
|
|
|
|
|
|
2012
|
|
2011
|
Net income
|
|
$
|
361,775
|
|
|
$
|
363,261
|
|
Adjustments:
|
|
|
|
|
Interest and other income (including amounts in discontinued
operations)
|
|
(6,158
|
)
|
|
(1,217
|
)
|
Interest (including amounts in discontinued operations)
|
|
302,031
|
|
|
242,057
|
|
Depreciation and amortization (including amounts in discontinued
operations)
|
|
764,774
|
|
|
459,704
|
|
General, administrative and professional fees (including amounts
in discontinued operations)
|
|
98,813
|
|
|
74,537
|
|
Loss on extinguishment of debt, net
|
|
37,640
|
|
|
27,604
|
|
Litigation proceeds, net
|
|
—
|
|
|
(202,259
|
)
|
Merger-related expenses and deal costs
|
|
63,183
|
|
|
153,923
|
|
Other (including amounts in discontinued operations)
|
|
8,842
|
|
|
8,653
|
|
(Income) loss from unconsolidated entities
|
|
(18,154
|
)
|
|
52
|
|
Income tax benefit (including amounts in discontinued operations)
|
|
(6,286
|
)
|
|
(31,137
|
)
|
Gain on real estate dispositions, net
|
|
(80,952
|
)
|
|
—
|
|
NOI (including amounts in discontinued operations)
|
|
1,525,508
|
|
|
1,095,178
|
|
Discontinued operations
|
|
(20,540
|
)
|
|
(27,017
|
)
|
NOI (excluding amounts in discontinued operations)
|
|
$
|
1,504,968
|
|
|
$
|
1,068,161
|
|
Non-GAAP Financial Measure Reconciliation
|
Same-Store Total Portfolio NOI
|
(Dollars in thousands)
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
December 31,
|
|
|
2012
|
|
2011
|
|
|
|
|
|
Net Operating Income
|
|
$
|
1,504,968
|
|
|
$
|
1,068,161
|
|
|
|
|
|
|
Less:
|
|
|
|
|
NOI Not Included in Same-Store
|
|
771,165
|
|
|
364,831
|
|
Straight-Lining of Rental Income
|
|
24,042
|
|
|
14,885
|
|
Non-Cash Rental Income
|
|
18,718
|
|
|
13,915
|
|
|
|
813,925
|
|
|
393,631
|
|
|
|
|
|
|
Same-Store Cash NOI
|
|
$
|
691,043
|
|
|
$
|
674,530
|
|
Pro Forma NOI with Management Fee Adjustment
|
|
(31,187
|
)
|
|
(17,392
|
)
|
|
|
|
|
|
Same-Store NOI with Management Fee Adjustment
|
|
$
|
722,230
|
|
|
$
|
691,922
|
|
|
|
|
|
|
Percentage Increase
|
|
|
|
4.4
|
%
|
|
Non-GAAP Financial Measure Reconciliation
|
Same-Store Seniors Housing Operating Portfolio NOI
|
(Dollars in thousands)
|
|
|
|
|
|
|
|
For the Years Ended
|
|
|
December 31,
|
|
|
2012
|
|
2011
|
|
|
|
|
|
Net Operating Income
|
|
$
|
99,418
|
|
|
$
|
89,202
|
|
|
|
|
|
|
Less:
|
|
|
|
|
NOI Not Included in Same-Store
|
|
8,793
|
|
|
428
|
|
Same-Store NOI
|
|
$
|
90,625
|
|
|
$
|
88,774
|
|
Management Fee Adjustment
|
|
(16,642
|
)
|
|
(12,246
|
)
|
|
|
|
|
|
Same-Store NOI with Management Fee Adjustment
|
|
$
|
107,267
|
|
|
$
|
101,020
|
|
|
|
|
|
|
Percentage Increase
|
|
|
|
6.2
|
%
|
Click
here to subscribe to Mobile Alerts for Ventas, Inc.